This article was written by Follow Alberto holds a Master’s degree in Business Economics. During his academic career he acquired an extensive managerial and...
This article was written by Follow As a tech-focused industry Research Analyst, I aim to provide differentiated insights, whether it is for investing, trading,...
This article was written by Follow Full time trader and investor. Instead of lengthy and boring articles, I prefer writing concise arguments about value...
There are few secrets in the semiconductor space, and that’s particularly true when you look at top-of-mind opportunities like silicon carbide (or SiC) and...
Welcome to another installment of our BDC Market Weekly Review, where we discuss market activity in the Business Development Company (“BDC”) sector from both...
Over the past few months, I have reviewed several funds from Simplify Asset Management. Some have been hits like the Simplify Volatility Premium ETF...
US This week will deliver a make-or-break moment for Fed rate hike expectations. The main event will be the September inflation report. Expectations are...
Topline Summary Nurix Therapeutics (NASDAQ:NRIX) is a biotech company specializing in the development of protein degraders, which are intended as a new class of...
The most recent U.S. jobs data suggests the employment sector may be showing signs of cooling. Rannella Billy-Ochieng’, Senior Economist at TD, speaks with...
Alpine Immune Sciences, Inc. (NASDAQ:ALPN) is a good speculative biotech play to look into. That’s because it expects to present preliminary results from an...